Clinical Trial Update: A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trastuzumab emtansine (T-DM1) sequenced with anthracycline-based chemotherapy as adjuvant or neoadjuvant therapy for early-stage HER2-p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anthracycline-based chemotherapy
• Trastuzumab Emtansine (Kadcyla) (trastuzumab emtansine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-06-26